Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 7,566 |
| Receivables | 229 |
| Inventories | 279 |
| Other current assets | 519 |
| TOTAL | $8,593 |
| Non-Current Assets | |
| PPE Net | 2,797 |
| Other Non-Current Assets | 170 |
| TOTAL | $2,967 |
| Total Assets | $10,451 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 550 |
| Accrued Expenses | 1,330 |
| TOTAL | $1,886 |
| Non-Current Liabilities | |
| TOTAL | $30 |
| Total Liabilities | $1,921 |
| Shareholders' Equity | |
| Common Shares | 1 |
| Retained earnings | -41,420 |
| Other shareholders' equity | 49,299 |
| TOTAL | $8,530 |
| Total Liabilities And Equity | $10,451 |